is retatrutide a glp 1 drug for weight loss: Study shows 30% body weight loss Retatrutide, an experimental weight-loss drug,

Expert consensus on the application of oral hypoglycemic drugs in patients with cardiovascular disease complicated with diabetes mellitus

: GLP-1 (2022 11) : GLP1RA ( ) ----------------------------------------------------------------- *

Obes Res (1998) 6(Suppl 2):51S209S

The problem is that some health insurance plans wont cover it for weight loss, and when they do, there might be several conditions the patient has to meet

NA, not applicable

The interest raised by this molecule is linked to the approval of DPP-4 inhibitors for T2D treatment (gliptins as vildagliptin, saxagliptin, alogliptin, sitagliptin, and linagliptin), as monotherapy or as an adjunctive agent with other drugs, with numerous advantages with respect to traditional treatments [53]